NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/18/2026
Back to search
Official data from USPTO
ALLAY PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLAY PHARMACEUTICALS
ST13
US500000088650542Class
40, 42
Filing
88650542
Registration
6057790
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
08/18/2026
Trademark type
Word
Nice classes
40, 42
Filing date
10/10/2019
Registration date
05/19/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2026
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/02/2006
First use in commerce
06/02/2006
Drawing code
4
Owner type
16
Owner location
Miami, FL, US
Examiner
INGOLD, GERALDINE
Current location
Historical data usage
Holders and representatives
Holders
Allay Pharmaceuticals, LLC
Representatives
Mark C. Johnson JOHNSON DALAL
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Biomanufacturing for othersmanufacturing of pharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of pharmaceuticals by pharmaceutical compounders
Class 42
Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical research and development; Testing of pharmaceuticals; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
19 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/18/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/17/2026
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2020
DOCK
ASSIGNED TO EXAMINER
01/15/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/29/2019
ALIE
ASSIGNED TO LIE
10/28/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2019
NWAP
NEW APPLICATION ENTERED
10/14/2019
Continuous trademark protection
Get notified about every new filing that threatens ALLAY PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.